New study in Cell uses Salipro technology for investigating autoimmune disease

Salipro® technology enables the determination of underlying mechanisms of autoimmune encephalitis. In a new study published in Cell, researchers identified anti-neuronal antibodies bound to the GABAA receptor by combining Salipro technology with cryoEM.

Congratulations to Noviello and the team for the identification of autoantibodies in complex with the Salipro-GABAA receptor!

Publication reference:
C. M. Noviello, et al., Structural mechanisms of GABAA receptor autoimmune encephalitis. Cell 185, 2469-2477 (2022).

Previous
Previous

Salipro Biotech Obtains Granted Patents in the United States and China for Direct Extraction of Membrane Proteins and Library Generation

Next
Next

Salipro Biotech presents new data in collaboration with AstraZeneca and Thermo Fisher Scientific